# EDGAR Filing Document

**Accession Number:** 0002021225
**File Stem:** 0001580642-26-002551
**Filing Date:** 2026-4
**Character Count:** 2220
**Document Hash:** 14964587c113cee0a7e5e1b205002fa5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001580642-26-002551.hdr.sgml**: 20260417

**ACCESSION NUMBER**: 0001580642-26-002551

**CONFORMED SUBMISSION TYPE**: 424B3

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260417

**DATE AS OF CHANGE**: 20260417

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Sardis Credit Opportunities Fund
- **CENTRAL INDEX KEY:** 0002021225

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 424B3
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-286563
- **FILM NUMBER:** 26870285

**BUSINESS ADDRESS:**
- **STREET 1:** 4200 NORTHSIDE PARKWAY
- **STREET 2:** BUILDING 4, SUITE 300
- **CITY:** ATLANTA
- **STATE:** GA
- **ZIP:** 30327
- **BUSINESS PHONE:** 833-442-7381

**MAIL ADDRESS:**
- **STREET 1:** 4200 NORTHSIDE PARKWAY
- **STREET 2:** BUILDING 4, SUITE 300
- **CITY:** ATLANTA
- **STATE:** GA
- **ZIP:** 30327

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Steadfast Structured Growth Fund
- **DATE OF NAME CHANGE:** 20240425

**SARDIS CREDIT OPPORTUNITIES FUND**

**Supplement dated April 17, 2026**

**to the Prospectus and Statement of Additional Information** 

**dated September 22, 2025**

This supplement updates certain information contained in the Prospectus and Statement of Additional Information, dated September 22, 2025, for the Sardis Credit Opportunities Fund (the "Fund"). You may obtain copies of the Fund's Prospectus free of charge online at www.sardisfunds.com, or upon request by calling toll-free 833-442-7381.

 ****

The Temporary Expense Limitation Agreement (as defined in the Prospectus in the section "Prospectus Summary – Fees and Expenses" and in the Statement of Additional Information in "Investment Advisory and Other Services – The Adviser"), which was scheduled to expire on April 30, 2026, will remain in effect through December 31, 2026, unless earlier terminated in accordance with its terms. All references to the Temporary Expense Limitation Agreement in the Prospectus and Statement of Additional Information are hereby revised to reference December 31, 2026 instead of April 30, 2026.

**Please retain this Supplement for future reference.**